glp 1 approved Novo's Wegovy becomes first GLP-1 drug for MASH Popular GLP-1 weight-loss drugs linked
Description
Studies reveal that regular use of metformin can lower fasting insulin levels by 14%, reduce HOMA-IR by 22%, and decrease the likelihood of developing type 2 diabetes by approximately 40%
Heart Health Stack Cardiovascular health support
However, the Inflation Reduction Act and subsequent CMS guidance opened a narrow door: plans may cover semaglutide when its prescribed for cardiovascular risk reduction in patients who already have established cardiovascular disease
Instead, the focus is on maintaining the internal balance necessary for healthy hair growth
